Results: Gene expression levels of miR-150-5p were significantly decreased in patients with active pulmonary TB disease as compared with either LTBI subjects (P = 0.021) or non-infected HS (P = 0.001). Subgroup analysis showed that gene expression levels of miR-23-3p, miR-146a-5p, miR-150-5p, and miR-155-5p were all decreased (all P values <0.05) in active TB patients with high bacterial burden (defined as sputum acid fast bacilli 3+ to 4+ at diagnosis) as compared with that in those with low bacterial burden (defined as sputum AFB 0 to 2+) or HS, and negatively correlated with sputum AFB gradings.
Conclusion: MiR-150-5p was down-regulated in active pulmonary TB patients, while miR-150-5p, miR-23-3p, miR-146a-5p, and miR-155-5p were all down-regulated in those with high bacterial burden. These findings provide biological insight into mechanisms by which Mycobacterium TB-suppressed miRs modulate human immunity, and indicate that overexpression of the miR-150 gene may be a new host-directed immunotherapy for active TB. Background and Aims: According to mechanism of extracellular matrix damage in patient with Pulmonary Tuberculosis is still poorly understood. The damage of the lung parenchyma is caused by production of metalloproteinase-9 which produced by Mycobacterium Tuberculosis. We hypothesized that there was correlation between MMP-9 and degree of severity chest X-Ray of pulmonary tuberculosis patient.
Methods:
We studied 30 subjects with minimal lesion and advanced lesion. MMP-9 level was examined and measured by Enzyme-linked assay (ELISA) and expressed with pg/mL. This research is an observational analytic with cross sectional design. Chi-square statistical analysis is used to analyzed the correlation between the two variables Results: Characteristics of the samples consist of 16 men and 10 women. Advanced lesions obtained 26 (86.7%) and minimal lesions obtained 4 (13.3%). The averaged levels of MMP-9 was higher significantly in advanced lesion compared to the minimal lesions (P < 0.000). Chi-square statistical analysis (P value: 0.048; P< 0.05), has a medium strength (coeff. contingency: 0.394) which is a significantly positive corre-
lation (unidirectional)
Conclusion: There is significantly positive correlation between the levels of MMP-9 and the severity degree of chest x-ray in patients with pulmonary tuberculosis at Dr. Soetomo General Hospital Surabaya with Methods: This retrospective study included all consecutive patients who were diagnosed with LE and TPE, respectively, between January 2011 and December 2016 at Kyungpook National University Hospital.
Clinical, laboratory, and pleural fluid characteristics were analyzed to find the independent variables that could discriminate between LE and TPE.
Results: Nineteen patients with LE and 216 patients with TPE were included in this study. Median age was 63 years in both LE and TPE groups. Fever was significantly more frequent in patients with TPE compared to those with LE (48% vs 11%, P = 0.001). Serum LDH levels were significantly higher in patients with LE than those with TPE (881 vs 371 U/L, P < 0.001). Pleural fluid ADA levels were commonly elevated in both groups with LE and TPE (66 vs 84 IU/L). In the multivariate analysis, fever was negatively associated with LE (Odds ratio [OR], 0.150; 95% confidence interval
[CI], 0.028-0.813; P = 0.028), while S-LDH levels were positively associated with LE (OR, 1.005; 95% CI, 1.003-1.007; P < 0.001). S-LDH >460 U/L provided a high negative predictive value (98%), with a sensitivity of 79% and specificity of 81% to distinguish LE and TPE. In addition, S-LDH >460 U/L without fever increased the specificity into 89%.
Conclusion:
Patients with LE and TPE present very similar clinical and pleural fluid characteristics. Fever and S-LDH levels may be helpful in the differential diagnosis of LE and TPE. Lymphoma should be kept in mind in the differential diagnosis in patients with lymphocytic pleural effusion and high ADA levels. Background and Aims: Cross-border referral of TB patients is important both for the patients themselves, and from the perspective of preventing antimicrobial resistance. In Japan, despite a sizeable proportion of TB patients moving out of Japan while still on treatment, there is currently no standardized system of cross-border referral. Their treatment outcome is often not followed-up, and are recorded as "transferred out".
